Atara Biotherapeutics Inc Shares Close the Day 12.9% Higher - Daily Wrap
The company saw its shares close the day 12.9% higher than yesterday, with trading volume lower than its 30 day average.
Jan 16, 2022 by Kwhen Finance Editors
Atara Biotherapeutics Inc (ATRA) shares closed today 12.9% higher than it did at the end of yesterday. The stock is currently up 2.0% year-to-date, down 14.7% over the past 12 months, and up 8.6% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%.
Trading Activity
- Shares traded as high as $16.23 and as low as $13.93 this week.
- Shares closed 26.5% below its 52-week high and 36.1% above its 52-week low.
- Trading volume this week was 34.6% lower than the 10-day average and 36.1% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | 12.9 | 2.0 | -14.7 | -34.1 | 21.9 |
| Dow Jones Industrial Average | -0.6 | -1.2 | 17.8 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 24.4 | -3.9 | 26.9 |
| Health Care | -0.2 | -5.7 | 12.9 | -6.8 | 19.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -117.2%
- The company's stock price performance over the past 12 months beats the peer average by -52.5%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | ATRA | 0 | 2.0 | -14.7 | -34.1 | 21.9 |
| Peer Avg | N/A | 47.4 | -11.4 | -31.0 | -61.0 | 14.2 |
| Immunogen, Inc. | IMGN | -18.6 | -12.5 | -14.4 | -41.3 | 35.4 |
| Agenus Inc | AGEN | 208.0 | -5.3 | -10.8 | -57.3 | 16.0 |
| Affimed N.V. | AFMD | 0 | -19.6 | -36.8 | -62.9 | 3.8 |
| Applied Genetic Technologies Corp | AGTC | 0 | -8.4 | -62.1 | -82.4 | 1.8 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: